📰 Merck Sharp News
Page 106 - Merck Sharp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Merck Sharp. Real-time updates on events, politics, business and more.
December 3, 2021
Report on Research Compliance 18, no. 12 (December, 2021) - A month after rumors circulated that President Biden planned to tap former Food and Drug Administration (FDA) ...
December 2, 2021
BERLIN--(BUSINESS WIRE)--Regulatory News:NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), hosted a Key Opinion Leader (KOL) event with Frank A. Giordano, M.D. on November 23, 2021, to discuss the combinati...
December 1, 2021
Molnupiravir, an oral antiviral pill for treating COVID-19, is in line for authorization by the FDA. The Tuesday vote recommending that it be prescribed to U.S. adults was a close one.
November 30, 2021
AstraZeneca cancer drug Lynparza is granted priority review in US | Financial News
November 30, 2021
Significance Statement This randomized trial demonstrates the safety and efficacy of conversion f
November 28, 2021
Professor Chris Whitty said the rollout of molnupiravir needs to be reconsidered to make sure it is targeted ‘in the right direction’.
November 28, 2021
Professor Chris Whitty said the rollout of molnupiravir needs to be reconsidered to make sure it is targeted ‘in the right direction’.
November 28, 2021
Professor Chris Whitty said the rollout of molnupiravir needs to be reconsidered to make sure it is targeted ‘in the right direction’.
November 28, 2021
Professor Chris Whitty said the rollout of molnupiravir needs to be reconsidered to make sure it is targeted ‘in the right direction’.
November 28, 2021
Professor Chris Whitty said the rollout of molnupiravir needs to be reconsidered to make sure it is targeted ‘in the right direction’.